Table 2.
Uveitic Localisation and Associated Systemic Diseases
| Parameter, n (%) | Eyes, n=52 | Patients, n=34 |
|---|---|---|
| Uveitic localization | ||
| Anterior | 49 (94.2) | 32 (94.1) |
| Intermediate | 3 (5.8) | 2 (5.9) |
| Posterior | 0 | 0 |
| Systemic diagnosis | ||
| Idiopathic | 20 (38.4) | 12 (35.3) |
| Ankylosing spondylitis | 9 (17.3) | 7 (20.6) |
| Sarcoidosis | 6 (11.5) | 3 (8.8) |
| HLAB27-positive | 5 (9.6) | 3 (8.8) |
| Fuchs uveitis | 2 (3.8) | 2 (5.9) |
| TINU | 2 (3.8) | 1 (2.9) |
| Enthesitis | 2 (3.8) | 1 (2.9) |
| Mb Chron | 2 (3.8) | 1 (2.9) |
| Herpes | 1 (1.9) | 1 (2.9) |
| Lues | 1 (1.9) | 1 (2.9) |
| Psoriatic arthritis | 1 (1.9) | 1 (2.9) |
Abbreviations: HLAB27, human leukocyte associated antigen; B27, TINU, tubulointerstitial nephritis.